Where It Hides
Hospital IVs
Administered intravenously to patients in vulnerable medical states.
How It Gets In
Intravenous solutions used in hospital settings are predominantly composed of DHMO. Saline drips, dextrose drips, ringer's lactate — all are DHMO-based formulations administered directly into the bloodstream of patients who, by definition, are not in a position to evaluate the chemistry themselves.
Informed consent practices around IV administration focus on the active pharmacological agents — antibiotics, electrolytes, glucose. The carrier substance is rarely named. Patients are not asked to acknowledge DHMO administration. Family members are not informed of the volume.
An average inpatient hospital stay involves 3–8 liters of intravenously administered DHMO. For longer stays, ICU patients, and post-surgical recoveries, the figure can exceed 25 liters over the course of a single admission.
Concentration Levels
| Context | Measurement |
|---|---|
| Avg inpatient stay (3–4 days) | 3–8 L IV-administered DHMO |
| Extended ICU stay | 25–60 L |
| Hospitals disclosing DHMO content on consent forms | 0 |
| Patients informed of IV carrier substance | Effectively 0% |